I agree that this site is using cookies. You can find further informations here.
X
Schultz, Liora Michal
122  results:
Search for persons X
?
1

Real World Outcomes for AYA Patients with Relapsed/Refracto..:

Lust, Hannah ; Roloff, Gregory ; Schultz, Liora Michal...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S39-S40 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S219-S220 , 2024
Link: https://doi.org/10.1016/..
 
?
3

CD22 CAR T-Cells Manufactured in Prodigy System and in Bag ..:

Dreyzin, Alexandra ; Kramer, Anne Marijn ; Yates, Bonnie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S182-S183 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Establishing Costs for Commercial Chimeric Antigen Receptor..:

Satwani, Prakash ; Chao, Karen ; Lopez-Garcia, Maria...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S224-S225 , 2024
Link: https://doi.org/10.1016/..
 
?
5

CD22 CAR T Cell Therapy Induces Durable Remissions in Patie..:

Frank, Matthew J. ; Sahaf, Bita ; Baird, John...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S1-S2 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Clinical Practice Patterns and Factors Driving Usage of Con..:

McNerney, Kevin O. ; Moskop, Amy ; Winestone, Lena E....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S205-S206 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Proinflammatory Cytokines are Associated with CAR-22 Macrop..:

Srinagesh, Hrishikesh K. ; Baird, John ; Patel, Shabnum...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S162-S163 , 2022
Link: https://doi.org/10.1016/..
 
?
8

DIPG-47. SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR..:

Monje, Michelle ; Mahdi, Jasia ; Majzner, Robbie G...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
9

CD22 CAR T cells demonstrate high response rates and safety..:

Schultz, Liora M. ; Jeyakumar, Nikeshan ; Kramer, Anne Marijn...
Leukemia.  38 (2024)  5 - p. 963-968 , 2024
Link: https://doi.org/10.1038/..
 
?
10

Real-world use of tisagenlecleucel in children and young ad..:

Bender, Jonathan D ; Damodharan, Sudarshawn ; Capitini, Christian M...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
11

Risk of T-cell malignancy after CAR T-cell therapy in child..:

Lamble, Adam J. ; Schultz, Liora M. ; Nguyen, Khanh...
Blood Advances.  8 (2024)  13 - p. 3544-3548 , 2024
Link: https://doi.org/10.1182/..
 
?
12

INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cel..:

Ligon, John A. ; Ramakrishna, Sneha ; Ceppi, Francesco...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. 155-170 , 2024
Link: https://doi.org/10.1016/..
 
?
13

INSPIRED Symposium Part 1: Clinical Variables Associated wi..:

Myers, Regina M. ; Jacoby, Elad ; Pulsipher, Michael A....
Transplantation and Cellular Therapy.  29 (2023)  10 - p. 598-607 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine.  65 (2023)  - p. 102268 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances.  7 (2023)  4 - p. 541-548 , 2023
Link: https://doi.org/10.1182/..
 
1-15